# Fasenra Pediatric Japan Post-Marketing Study(PMS)

> **NCT06427876** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 40 (estimated)

## Conditions studied

- Bronchial Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06427876
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-16
- **Primary completion:** 2027-03-17
- **Final completion:** 2027-03-17
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06427876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06427876, "Fasenra Pediatric Japan Post-Marketing Study(PMS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06427876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*